Dr Gliddon's research focuses on developing molecular diagnostics for infectious diseases. By coupling novel molecular biology techniques to advanced nanomaterials, we can develop extremely rapid diagnostics with high sensitivities and specificities.
Molecular diagnostics (i.e. those that detect specific DNA or RNA sequences within a pathogen's genome) allow us to respond to infectious disease outbreaks with increased agility since they can be developed in a short space of time compared to serologic diagnostic tests (i.e. those that rely on antigen-antibody binding).